Market Movers (8-K)
NYSE
GMR Solutions Inc. announced its financial results for the second quarter of 2026, reporting a 3.3% increase in net revenue but a significant decrease in net income and Adjusted EBITDA compared to the prior year.
Capital raise
Worse than expected
NYSE
GMR Solutions Inc. announces finalized committee assignments for newly appointed director Jan Stern Reed, effective July 1, 2026.
NYSE
GMR Solutions Inc. announced the appointment of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026, enhancing the board's expertise in healthcare delivery and governance.
Quarterly Earnings (10-Q)
NYSE
GMR Solutions Inc. reported a net loss of $28.3 million for the second quarter of 2026, a significant decline from the prior year's net income, driven by increased operating expenses despite a modest revenue increase.
Capital raise
Worse than expected
Insider Trading (Form 4)
NYSE
GMR Solutions Inc. director Ellen M. Zane acquired 9,972 restricted stock units (RSUs) on July 1, 2026, which vest on July 1, 2027.
NYSE
GMR Solutions Inc. Director Amar Desai acquired 9,972 Restricted Stock Units (RSUs) on July 1, 2026, which vest on July 1, 2027.
Schedule 13G - Passive Investments
NYSE
Several KKR-affiliated entities and individuals have filed a joint Schedule 13G statement, disclosing beneficial ownership of over 81% of GMR Solutions Inc.'s Class A common stock.
NYSE
Invesco Ltd. has reported beneficial ownership of 5.7% of GMR Solutions Inc.'s common stock as of June 30, 2026.
NYSE
Norges Bank has reported a beneficial ownership of 5.46% in GMR Solutions Inc. common stock as of June 30, 2026.